Gene · 7832
Papers2,269
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,269
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of BTG2/PI3K/AKT pathway-mediated microglial activation in T-2 toxin-induced neurotoxicity. | Toxicol Lett | 2024 | 39147216 | PubTator, text mining | PubMed |
| IRF4 Suppresses Osteogenic Differentiation of Periodontal Ligament Stem Cells by Activating IL-18 Signaling Pathway in Periodontitis. | Adv Biol (Weinh) | 2024 | 39078121 | PubTator, text mining | PubMed |
| Diagnosis and Molecular Characterization of Potential RNA Binding Protein Involved in the Pathogenesis of Liver Ischemia Reperfusion Injury. | J Inflamm Res | 2024 | 39070133 | PubTator, text mining | PubMed |
| Circulating tumor DNA assisting lymphoma genetic feature profiling and identification. | Ann Hematol | 2024 | 39012515 | PubTator, text mining | PubMed |
| Unraveling the noncoding RNA landscape in glioblastoma: from pathogenesis to precision therapeutics. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 39007929 | PubTator, text mining | PubMed |
| Targeting HTR2B suppresses nonfunctioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Gαq/PLC/PKCγ/STAT3 axis. | Neuro Oncol | 2024 | 38989697 | PubTator, text mining | PubMed |
| Merkel cell polyomavirus pan-T antigen knockdown reduces cancer cell stemness and promotes neural differentiation independent of RB1. | J Med Virol | 2024 | 38988206 | PubTator, text mining | PubMed |
| Disease types and pathogenic mechanisms induced by PM2.5 in five human systems: An analysis using omics and human disease databases. | Environ Int | 2024 | 38959566 | PubTator, text mining | PubMed |
| Transcriptional activation of candidate paused genes after partial hepatectomy. | MicroPubl Biol | 2024 | 38919542 | PubTator, text mining | PubMed |
| Deciphering the molecular nexus of BTG2 in periodontitis and diabetic kidney disease. | BMC Med Genomics | 2024 | 38831322 | PubTator, text mining | PubMed |
| Delineating the mechanistic relevance of the TP53 gene and its mutational impact on gene expression and patients' survival in bladder cancer. | Heliyon | 2024 | 38803860 | PubTator, text mining | PubMed |
| A Brain Anti-Senescence Transcriptional Program Triggered by Hypothalamic-Derived Exosomal microRNAs. | Int J Mol Sci | 2024 | 38791505 | PubTator, text mining | PubMed |
| Anchorage Dependence and Cancer Metastasis. | J Korean Med Sci | 2024 | 38769921 | PubTator, text mining | PubMed |
| Reprogramming anchorage dependency to develop cell lines for recombinant protein expression. | Biotechnol J | 2024 | 38700448 | PubTator, text mining | PubMed |
| Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression. | Crit Rev Biochem Mol Biol | 2024 | 38661126 | PubTator, text mining | PubMed |
| Prognostic effect of DNA methylation of BTG2 gene in Chinese hepatocellular carcinoma. | Heliyon | 2024 | 38560180 | PubTator, text mining | PubMed |
| DELVE: feature selection for preserving biological trajectories in single-cell data. | Nat Commun | 2024 | 38553455 | PubTator, text mining | PubMed |
| Exploring diverse programmed cell-death patterns to develop a novel gene signature for predicting the prognosis of lung adenocarcinoma patients. | J Thorac Dis | 2024 | 38505063 | PubTator, text mining | PubMed |
| Analysis and experimental validation of IL-17 pathway and key genes as central roles associated with inflammation in hepatic ischemia-reperfusion injury. | Sci Rep | 2024 | 38494504 | PubTator, text mining | PubMed |
| Retraction: miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis. | J Cell Mol Med | 2024 | 38396328 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7832/papers?page=6